Avalon Investment & Advisory Gilead Sciences, Inc. Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Avalon Investment & Advisory holds 253,084 shares of GILD stock, worth $23.4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

253,084

Previous 391,021 35.28%

Holding current value

$23.4 Million

Previous $33.6 Million 37.45%

% of portfolio

0.59%

Previous 0.96%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $10.7 Million - $12.1 Million	-137,937 Reduced 35.28%	253,084 $21 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $42.6 Million - $61.1 Million	-683,314 Reduced 63.6%	391,021 $33.6 Million
Q3 2022 Nov 01, 2022	SELL	$59.54 - $68.01 $1.12 Million - $1.28 Million	-18,888 Reduced 1.73%	1,074,335 $66.3 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $171,082 - $192,689	-2,964 Reduced 0.27%	1,093,223 $67.6 Million
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $3.29 Million - $4.12 Million	56,764 Added 5.46%	1,096,187 $65.2 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $7.91 Million - $8.98 Million	-121,886 Reduced 10.5%	1,039,423 $75.5 Million
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $461,578 - $497,991	6,819 Added 0.59%	1,161,309 $81.1 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $27.5 Million - $30.1 Million	433,661 Added 60.16%	1,154,490 $79.5 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $3.25 Million - $3.71 Million	54,174 Added 8.13%	720,829 $46.6 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $5.16 Million - $5.88 Million	-91,046 Reduced 12.02%	666,655 $38.8 Million
Q3 2020 Nov 04, 2020	SELL	$62.1 - $78.08 $4.12 Million - $5.18 Million	-66,330 Reduced 8.05%	757,701 $47.9 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $3.53 Million - $4.1 Million	-48,839 Reduced 5.6%	824,031 $63.4 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $10 Million - $12.8 Million	-159,993 Reduced 15.49%	872,870 $65.3 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $32.1 Million - $35.4 Million	521,727 Added 102.07%	1,032,863 $67.1 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.57 Million - $1.74 Million	25,183 Added 5.18%	511,136 $32.4 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.12 Million - $2.37 Million	34,217 Added 7.57%	485,953 $32.8 Million
Q1 2019 Apr 24, 2019	SELL	$62.53 - $70.05 $8.57 Million - $9.6 Million	-137,102 Reduced 23.28%	451,736 $29.4 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.15 Million - $1.5 Million	19,048 Added 3.34%	588,838 $36.8 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $5.95 Million - $6.59 Million	83,524 Added 17.18%	569,790 $44 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $7.94 Million - $9.26 Million	122,332 Added 33.61%	486,266 $34.4 Million
Q1 2018 Jun 26, 2018	BUY	$72.84 - $88.8 $3.76 Million - $4.58 Million	51,569 Added 16.51%	363,934 $27.4 Million
Q1 2018 Jun 22, 2018	SELL	$72.84 - $88.8 $4.36 Million - $5.31 Million	-59,845 Reduced 16.08%	312,365 $22.4 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $4.36 Million - $5.31 Million	59,845 Added 19.16%	372,210 $28.1 Million
Q4 2017 Jun 22, 2018	SELL	$71.15 - $83.52 $1.02 Million - $1.2 Million	-14,330 Reduced 4.39%	312,365 $22.4 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $738,750 - $867,188	10,383 Added 3.28%	326,695 $23.4 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.34 Million - $1.59 Million	18,576 Added 6.24%	316,312 $25.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	297,736	297,736 $21.1 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Gilead Sciences, Inc. Transaction History